Presentation TCT 2014 Two-Year Clinical Results of Patients Randomized to 3- or 12-Month Dual Antiplatelet After Endeavor Zotarolimus Eluting Stent Implantation In OPTIMIZE Presenter: Fausto Feres September 16, 2014 REGISTER for free or LOG IN to view this content CAD Pharma Presentation TCT 2014 Up Next Presentation TCT 2014 Yes: WOEST Definititely Proves Safety and Likely Efficacy as Well! Presenter: Harvey D. White September 14, 2014 More slides + Presentation TCT 2013 Vulnerable Plaque Diagnosis by Grayscale and Radiofrequency IVUS (with Case Vignettes) Presenter: Patrick Calvert October 30, 2013 Presentation TCT 2013 How Would I Treat This Patient?(5) Presenter: Mohd Ali Rosli October 30, 2013 We Recommend
Presentation TCT 2014 Yes: WOEST Definititely Proves Safety and Likely Efficacy as Well! Presenter: Harvey D. White September 14, 2014
Presentation TCT 2013 Vulnerable Plaque Diagnosis by Grayscale and Radiofrequency IVUS (with Case Vignettes) Presenter: Patrick Calvert October 30, 2013